EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Pfizer's Enterprise Value is $190,843 Mil.
Pfizer's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was $10,341 Mil. Therefore, Pfizer's EV-to-EBIT for today is 18.45.
The historical rank and industry rank for Pfizer's EV-to-EBIT or its related term are showing as below:
PFE'
s EV-to-EBIT Range Over the Past 10 Years
Min: -195.64 Med: 18.63 Max: 3289.46
Current: 18.45
During the past 13 years, the highest EV-to-EBIT of Pfizer was 3289.46. The lowest was -195.64. And the median was 18.63.
PFE's EV-to-EBIT is ranked worse than 51.18% of 680
companies
in the Drug Manufacturers industry
Industry Median: 18.035
vs PFE: 18.45
The historical data trend for Pfizer's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Pfizer's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pfizer's EV-to-EBIT Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pfizer's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Pfizer's EV-to-EBIT falls into.
Pfizer's current Enterprise Value is $190,843 Mil.
Pfizer's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $10,341 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pfizer (NYSE:PFE) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Pfizer's Enterprise Value for the quarter that ended in Mar. 2025 was $188,332 Mil.
Pfizer's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $10,341 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pfizer EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Pfizer's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PFE has been successfully added to your 